Tesamorelin vs MOTS-C: Research Comparison
Tesamorelin and MOTS-C are both studied in metabolic research, but they sit at opposite ends of the cellular signaling chain. Tesamorelin acts at the top of the GH/IGF-1 axis — stimulating the pituitary to release growth hormone. MOTS-C acts at the bottom — inside the mitochondria, activating AMPK and influencing nuclear gene expression directly. Understanding this distinction is central to designing research protocols that target one pathway, the other, or both.
Quick Reference Comparison
| Property | Tesamorelin | MOTS-C |
|---|---|---|
| Class | GHRH analogue (44 amino acids) | Mitochondrial-derived peptide (16 amino acids) |
| Primary target | Pituitary GHRH receptor | AMPK pathway / nuclear gene expression |
| Pathway level | Upstream — GH/IGF-1 axis | Downstream — cellular energy sensing |
| Primary research focus | Visceral fat, lean mass, IGF-1 | Insulin sensitivity, fat oxidation, aging biology |
| Available sizes | 10mg | 10mg, 40mg |
| Starting price | $80 | $50 |
| Reconstitution | 2mL BAC/10mg (5mg/mL) | 1mL BAC/10mg (10mg/mL) |
Mechanism: GH Axis vs AMPK
Tesamorelin — top-down, GH axis: Tesamorelin binds GHRH receptors on pituitary somatotroph cells, stimulating endogenous growth hormone release in its natural pulsatile pattern. This in turn drives hepatic IGF-1 production. Its research focus follows this chain: GHRH receptor → pulsatile GH → IGF-1 → downstream metabolic effects, most notably on visceral adipose tissue.
MOTS-C — bottom-up, mitochondrial/AMPK: MOTS-C is itself encoded in the mitochondrial genome. Research indicates it activates AMPK, the cell's energy-sensing enzyme, directly promoting glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. Under metabolic stress, MOTS-C can translocate to the nucleus and influence gene expression — a retrograde signaling pathway distinct from any hormone-receptor cascade.
Research Use Cases
Use tesamorelin when: The research question concerns the GH/IGF-1 axis specifically — pulsatile GH secretion, IGF-1 production, visceral adipose tissue, or lean mass preservation. Tesamorelin is also the appropriate reference compound for comparative research against other GHRH analogues or GH secretagogues.
Use MOTS-C when: The research question concerns AMPK pathway activation, mitochondrial function, insulin sensitivity, fat oxidation, or mitochondria-to-nucleus retrograde signaling. MOTS-C is also relevant to aging-biology research, since endogenous levels decline with age.
Use both when: The research design calls for characterizing combined effects on glucose and lipid metabolism from two non-overlapping mechanisms — one acting through a classical hormone axis, the other through direct cellular energy sensing.
Studying Both Together
Because tesamorelin's GH/IGF-1 axis activity and MOTS-C's AMPK/mitochondrial activity are mechanistically distinct, the two are sometimes studied in parallel or combined research protocols to characterize additive or interactive effects on body composition and metabolic markers. Since neither pathway directly antagonizes the other, comparative designs can isolate which observed effects are attributable to each mechanism.
MOTS-C — 10mg vial — $50 · 40mg vial — $155. View product details →
Reconstitution Differences
Both compounds reconstitute with Bacteriostatic Water into clear, colorless solutions, and both are stable 28-42 days when refrigerated at 2-8°C — but the standard concentrations differ.
Tesamorelin (10mg): Add 2mL BAC Water for a 5mg/mL concentration.
MOTS-C (10mg): Add 1mL BAC Water for a 10mg/mL concentration. MOTS-C (40mg): Add 4mL BAC Water, also yielding 10mg/mL.
In both cases, inject BAC Water slowly down the vial wall and swirl gently — do not shake. Reconstitute each compound separately in its own vial; do not mix tesamorelin and MOTS-C in the same vial. For full reconstitution parameters and a dosing calculator that computes exact draw volumes, visit our Reconstitution Guide and Dosing Calculator.